effect hydroxyurea hemoglobin water content red blood cell dog patient sickl cell anemia rational clinic trial hydroxyurea HU treatment sickl cell diseas agent increas blood cell rbc hemoglobin content addit effect HU mean corpuscular volum mcv action HU speci distinguish fetal hemoglobin dog drug respons patient sickl cell anemia dog patient increas mcv effect HU treatment mean corpuscular hemoglobin concentr mchc densiti water content rbc speci dog rbc low mchc high ion water content low mean densiti HU mcv mchc fetal hemoglobin synthesi differ pattern sickl cell patient HU treatment mcv rbc chang mchc ion content mean densiti notabl chang sickl cell patient blood subpopul cell HU treatment hypodens reticulocyt fraction hyperdens fraction sickl cell find trial HU sickl cell diseas possibl benefici effect agent due increas hemoglobin associ increas mcv alter rbc densiti profil 